Literature DB >> 25457756

FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity.

Joshua Lehrer-Graiwer, Parmanand Singh, Amr Abdelbaky, Esad Vucic, Magnus Korsgren, Amos Baruch, Jill Fredrickson, Nick van Bruggen, Meina T Tang, Bjorn Frendeus, James H F Rudd, Frank Hsieh, Christie M Ballantyne, Brian Ghoshhajra, Robert S Rosenson, Michael Koren, Eli M Roth, Daniel A Duprez, Zahi A Fayad, Ahmed A Tawakol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25457756     DOI： 10.1016/j.jcmg.2014.06.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  23 in total

Review 1.  Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

2.  [Immunity and inflammation in atherosclerosis].

Authors:  D Wolf; K Ley
Journal:  Herz       Date:  2019-04       Impact factor: 1.443

Review 3.  The immunology of atherosclerosis.

Authors:  Anton Gisterå; Göran K Hansson
Journal:  Nat Rev Nephrol       Date:  2017-04-10       Impact factor: 28.314

4.  Amygdalar activity predicts future incident diabetes independently of adiposity.

Authors:  Michael T Osborne; Amorina Ishai; Basma Hammad; Brian Tung; Ying Wang; Amos Baruch; Zahi A Fayad; Jon T Giles; Janet Lo; Lisa M Shin; Steven K Grinspoon; Karestan C Koenen; Roger K Pitman; Ahmed Tawakol
Journal:  Psychoneuroendocrinology       Date:  2018-09-22       Impact factor: 4.905

Review 5.  Atherosclerosis.

Authors:  Kouji Kobiyama; Klaus Ley
Journal:  Circ Res       Date:  2018-10-26       Impact factor: 17.367

6.  Regulatory CD4+ T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein B.

Authors:  Takayuki Kimura; Kouji Kobiyama; Holger Winkels; Kevin Tse; Jacqueline Miller; Melanie Vassallo; Dennis Wolf; Christian Ryden; Marco Orecchioni; Thamotharampillai Dileepan; Marc K Jenkins; Eddie A James; William W Kwok; David B Hanna; Robert C Kaplan; Howard D Strickler; Helen G Durkin; Seble G Kassaye; Roksana Karim; Phyllis C Tien; Alan L Landay; Stephen J Gange; John Sidney; Alessandro Sette; Klaus Ley
Journal:  Circulation       Date:  2018-09-11       Impact factor: 29.690

7.  A clinically applicable adjuvant for an atherosclerosis vaccine in mice.

Authors:  Kouji Kobiyama; Melanie Vassallo; Jessica Mitzi; Holger Winkels; Hong Pei; Takayuki Kimura; Jacqueline Miller; Dennis Wolf; Klaus Ley
Journal:  Eur J Immunol       Date:  2018-08-12       Impact factor: 5.532

Review 8.  Immunity and Inflammation in Atherosclerosis.

Authors:  Dennis Wolf; Klaus Ley
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

9.  Inverse association of ApoB and HSP60 antibodies with coronary artery disease in Indian population.

Authors:  Thiruvelselvan Ponnusamy; Srikanth K Venkatachala; Manjunatha Ramanjappa; Vijay V Kakkar; Lakshmi A Mundkur
Journal:  Heart Asia       Date:  2018-06-26

Review 10.  Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

Authors:  Justine Deroissart; Florentina Porsch; Thomas Koller; Christoph J Binder
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.